Two-year reduction of panel reactive human leukocyte antigen antibodies in children receiving mycophenolate mofetil after valved allograft placement

Transplantation

Volumn 80, Issue 3, 2005, Pages 414-416

  Anderson, Jeffrey B ^a   Fuller, Thomas C ^b   Hawkins, John A ^b   Brinkman, Maureen K ^b   Profaizer, Tracie ^b   Shaddy, Robert E ^b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

Allograft; Heart valve; HLA antibody; Mycophenolate mofetil; Pediatric

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADOLESCENT; ALLOGRAFT; ALLOIMMUNITY; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; AORTA VALVE REPLACEMENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FALLOT TETRALOGY; FLOW CYTOMETRY; FOLLOW UP; GRAFT REJECTION; HEART VALVE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; PULMONARY VALVE DISEASE;

ADOLESCENT; ANTIBODIES; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GRAFT REJECTION; HEART DEFECTS, CONGENITAL; HEART VALVES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOLOGIC TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; MYCOPHENOLIC ACID; PILOT PROJECTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 23744492512     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000168215.51902.a0     Document Type: Article

References (15)

1. Shaddy RE, Hunter DD, Osborn KA, et al. Prospective analysis of HLA immunogenidly of cryopreserved valved allografts used in pediatric heart surgery. Circulation 1996; 94: 1063.
2. Shaddy RE, Hunter DD, Osborn KA, et al. Persistence of human leukocyte antigen (HLA) antibodies after one year in children receiving cryopreserved valved allografts. Am J Cardiol 1997; 80: 358.
3. Hawkins JA, Brienholt JP, Lambert LM, et al. Class I, and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Cardiovasc Surg 2000; 119: 324.
4. Breinholt JP III, Hawkins JA, Lambert LM, et al. A propective analysis of the immunogenity of cryopreserved nonvalved allografts used in pediatric heart surgery. Circulation 2000; 102(Suppl 3): III179.
5. Hooper DK, Hawkins JA, Lambert LM, et al. Panel-reactive antibodies late after allograft implantation in children. Ann of Thorac Surg 2005; 79(2): 641.
6. Hoekstra F, Wirvliet M, Knoop C, et al. Donor-specific anti-human leukocyte antigen class I antibodies after implantation of cardiac valve allografts. J Heart Lung Transplant 1997; 16(5): 570.
7. Heokstra FM, Witvliet M, Knoop CY, et al. Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies. Ann Thorac Surg 1998; 66(6): 2022.
8. Vogt PR, Stallmach T, Niederhauser U, et al. Explanted cryopreserved allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults. Eur J Cardiothorac Surg 1999; 15(5): 639; discussion 644.
9. Dignan R, O'Brien M, Hogan P, et al. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens. J Heart Valve Dis 2003; 12(3): 382; discussion 390.
10. Rajani B, Mee RB, Ratliff NB. Evidence for rejection of homograft cardiac valves in infants. J Thorac Cardiovasc Surg 1998; 115(1): 111.
11. Smith JD, Danskine AJ, Rose ML, Yacoub MH. Specificity of lymphocytotoxic antibodies formed after cardiac transplantation and correlation with rejection episodes. Transplantation 1992; 53(6): 1358.
12. Smith JD, Danskine AJ, Laylor RM, et al. The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation. Transpl Immunol 1993; 1(1): 60.
13. Mahle WT, Naftel DC, Rusconi P, et al. Panel-reactive antibody cross-reactivity and outcomes in the pediatric heart transplant study group. J Heart Lung Transplant 2004; 23: S167.
14. Shaddy RE, Fuller TC, Anderson JA, et al. Mycophenolic Mofetil reduces the HLA antibody response of children to valved allograft implantation. Ann Thorac Surg 2004; 77: 1734.
15. Koch CA, Khalpey ZI, Platt JL. Accommodation: preventing injury in transplantation. J Immunol 2004; 172: 5143.